Ticagrelor + placebo for non-st elevated myocardial infarction

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Dec 2025: Trial registered, NCT07257198
  2. 3 Mar 2026: Trial started, NCT07257198

The trials

NCT07257198: Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone

State
Under way
Phase
Phase 3
People
2,570 planned
Started
3 Mar 2026
Primary completion
1 Jan 2030
Arms
Ticagrelor monotherapy
Results
None posted
  1. 2 Dec 2025: Trial registered
  2. 3 Mar 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.